Allergy Therapeutics moves ahead with peanut and grass pollen allergy trials
Allergy Therapeutics has announced the first subject has been dosed in the pivotal phase III…
December 8, 2022 - 3 minutes
Allergy Therapeutics
Shares Drop 40% as Allergy Therapeutics Announces Failed Phase III Trial
Allergy Therapeutics has revealed that its immunotherapy for birch pollen allergy did not result in…
March 18, 2019 - 2 minutes
Positive House Dust Mite Immunotherapy Results for UK Biotech
British biotech Allergy Therapeutics reports positive early-stage results for its house dust mite immunotherapy. It’s…
May 29, 2018 - 1 minute
Grass Pollen Allergy Vaccine Gets Encouraging Phase II Results
Allergy Therapeutics has obtained positive Phase II results for its grass pollen allergy vaccine and…
May 23, 2018 - 2 minutes
British Rapid Action Allergy Vaccine Gets Approval for Phase II Trial
Allergy Therapeutics' vaccine against hayfever has received approval to begin a trial to determine its…
September 18, 2017 - 2 minutes
Suffering from House Dust Mite Allergy? A New Therapy is on its Way
Allergy Therapeutics, a UK-based biotech company, just announced the approval of its clinical trial application…
February 14, 2017 - 2 minutes
Germany gains Strength in Allergy Immunotherapeutics
Bencard Allergie is developing ultra-short course allergy immunotherapies, backed by a strong growth in its…
February 10, 2017 - 2 minutes
UK Biopharma joins Allergy race with good Phase II results for Hayfever
Allergy Therapeutics has gotten positive results for its phase II trial for birch pollen allergy…
May 9, 2016 - 2 minutes
